|
Status |
Public on Mar 02, 2021 |
Title |
Bcl-xAS-transfected 786-O cells_replicate 3_Cy5 vs. Control empty vector-transfected 786-O cells_replicate 3_Cy3 |
Sample type |
RNA |
|
|
Channel 1 |
Source name |
Bcl-xAS-transfected 786-O cells
|
Organism |
Homo sapiens |
Characteristics |
cell line: 786-O original tissue: clear cell renal cell cancer (CCRCC) transfection: Bcl-xAS
|
Treatment protocol |
Cells were transfected with 6 μg of Bcl-xAS expression construct or with 6 μg of empty vector (pCEP) as control using 3:1 FuGENE HD reagent (Promega). At 24 h after transfection, total RNA was extracted.
|
Growth protocol |
786-O cells were cultivated in 147.8 cm2 cell culture plates with Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% FBS. To perform four biological replicates, we cultivated four plates in parallel.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted with Trizol reagent following the manufacturer's instructions. Total RNA was DNase-I-treated and purified using the Illustra RNAspin Mini kit (GE Healthcare) following the manufacturer's instructions.
|
Label |
Cy5
|
Label protocol |
200 ng of total RNA was labelled following the Agilent Two-color Low Input Quick Amp Labeling Protocol Version 6.5.
|
|
|
Channel 2 |
Source name |
Control empty vector-transfected 786-O cells
|
Organism |
Homo sapiens |
Characteristics |
cell line: 786-O original tissue: clear cell renal cell cancer (CCRCC) transfection: control
|
Treatment protocol |
Cells were transfected with 6 μg of Bcl-xAS expression construct or with 6 μg of empty vector (pCEP) as control using 3:1 FuGENE HD reagent (Promega). At 24 h after transfection, total RNA was extracted.
|
Growth protocol |
786-O cells were cultivated in 147.8 cm2 cell culture plates with Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% FBS. To perform four biological replicates, we cultivated four plates in parallel.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted with Trizol reagent following the manufacturer's instructions. Total RNA was DNase-I-treated and purified using the Illustra RNAspin Mini kit (GE Healthcare) following the manufacturer's instructions.
|
Label |
Cy3
|
Label protocol |
200 ng of total RNA was labelled following the Agilent Two-color Low Input Quick Amp Labeling Protocol Version 6.5.
|
|
|
|
Hybridization protocol |
300 ng of cRNA was hybridized following the Agilent Two-color Low Input Quick Amp Labeling Protocol Version 6.5.
|
Scan protocol |
Scanned on an Agilent G2565CA Microarray Scanner System.
|
Description |
Bcl-xAS_rep3_Cy5/Ctl_rep3_Cy3 Bcl-xAS-transfected 786-O cells, biological replicate 3 of 4, Cy5 labelled vs. empty vector-transfected 786-O cells, biological replicate 3 of 4, Cy3 labelled.
|
Data processing |
Linear and lowess-normalized data (Processed Signal Column by Feature Extractor Agilent Software v.10.7.1.1) was transformed to log2 ratios for test/reference samples.
|
|
|
Submission date |
Jun 17, 2012 |
Last update date |
Mar 02, 2021 |
Contact name |
Angela A. Fachel |
E-mail(s) |
anf2032@med.cornell.edu
|
Organization name |
Weill Cornell Medicine
|
Street address |
1300 York Ave
|
City |
New York |
State/province |
New York |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platform ID |
GPL13607 |
Series (1) |
GSE38766 |
Expression profile of human 786-O cells overexpressing Bcl-xAS lncRNA |
|